557
Views
9
CrossRef citations to date
0
Altmetric
Short Communications

Respiratory failure in confirmed synthetic cannabinoid overdose

ORCID Icon, , ORCID Icon, , ORCID Icon, , & ORCID Icon show all
Pages 524-526 | Received 04 Jun 2021, Accepted 28 Aug 2021, Published online: 09 Sep 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

K. M. Scarfone, N. Maghsoudi, K. McDonald, H. Thompson, C. Stefan, D. R. Beriault, D. Werb & J. M. Bowles. (2022) Emerging synthetic cannabinoids detected by a drug checking service in Toronto, Canada. Clinical Toxicology 60:8, pages 979-984.
Read now

Articles from other publishers (8)

Caitlyn Norman, Marie H. Deventer, Olivia Dremann, Robert Reid, Katleen Van Uytfanghe, Claude Guillou, Inge M. J. Vinckier, Niamh Nic Daéid, Alex Krotulski & Christophe P. Stove. (2023) In vitro cannabinoid receptor activity, metabolism, and detection in seized samples of CH‐PIATA, a new indole‐3‐acetamide synthetic cannabinoid. Drug Testing and Analysis.
Crossref
Mariana Campello de Oliveira, Mariana Capelo Vides, Dângela Layne Silva Lassi, Julio Torales, Antonio Ventriglio, Henrique Silva Bombana, Vilma Leyton, Cintia de Azevedo-Marques Périco, André Brooking Negrão, André Malbergier & João Maurício Castaldelli-Maia. (2023) Toxicity of Synthetic Cannabinoids in K2/Spice: A Systematic Review. Brain Sciences 13:7, pages 990.
Crossref
Merja A. Neukamm, Sebastian Halter, Volker Auwärter, Georg Schmitt, Arianna Giorgetti & Marc Bartel. (2023) Death after smoking of fentanyl, 5F-ADB, 5F-MDMB-P7AICA and other synthetic cannabinoids with a bucket bong. Forensic Toxicology.
Crossref
Jiahong Xiang, Di Wen, Junbo Zhao, Ping Xiang, Yan Shi & Chunling Ma. (2023) Study of the Metabolic Profiles of “Indazole-3-Carboxamide” and “Isatin Acyl Hydrazone” (OXIZID) Synthetic Cannabinoids in a Human Liver Microsome Model Using UHPLC-QE Orbitrap MS. Metabolites 13:4, pages 576.
Crossref
David B. Finlay, Warwick Mackie, Hunter D.J. Webb, Lucy R. Thomsen, Mhairi Nimick, Rhonda J. Rosengren, Julie A. Marusich, Michelle Glass & Jenny L. Wiley. (2023) The piperazine analogue para-fluorophenylpiperazine alters timing of the physiological effects of the synthetic cannabinoid receptor agonist AMB-FUBINACA, without changing its discriminative stimulus, signalling effects, or metabolism. Pharmacology Biochemistry and Behavior 223, pages 173530.
Crossref
Eric Sparkes, Rochelle Boyd, Shuli Chen, Jack W. Markham, Jia Lin Luo, Tahira Foyzun, Humayra Zaman, Charlotte Fletcher, Ross Ellison, Iain S. McGregor, Marina J. Santiago, Felcia Lai, Roy R. Gerona, Mark Connor, David E. Hibbs, Elizabeth A. Cairns, Michelle Glass, Adam Ametovski & Samuel D. Banister. (2022) Synthesis and pharmacological evaluation of newly detected synthetic cannabinoid receptor agonists AB-4CN-BUTICA, MMB-4CN-BUTINACA, MDMB-4F-BUTICA, MDMB-4F-BUTINACA and their analogs. Frontiers in Psychiatry 13.
Crossref
Marie H. Deventer, Katleen Van Uytfanghe, Inge M. J. Vinckier, Fabiano Reniero, Claude Guillou & Christophe P. Stove. (2022) Cannabinoid receptor activation potential of the next generation, generic ban evading OXIZID synthetic cannabinoid receptor agonists. Drug Testing and Analysis 14:9, pages 1565-1575.
Crossref
Jack Markham, Eric Sparkes, Rochelle Boyd, Shuli Chen, Jamie J. Manning, David Finlay, Felcia Lai, Eila McGregor, Callan J. Maloney, Roy R. Gerona, Mark Connor, Iain S. McGregor, David E. Hibbs, Michelle Glass, Richard C. Kevin & Samuel D. Banister. (2022) Defining Steric Requirements at CB 1 and CB 2 Cannabinoid Receptors Using Synthetic Cannabinoid Receptor Agonists 5F-AB-PINACA, 5F-ADB-PINACA, PX-1, PX-2, NNL-1, and Their Analogues . ACS Chemical Neuroscience 13:8, pages 1281-1295.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.